SLI
1 992,10
|
15,26
|
0,77 %
|
Analysen zu SLI-Werten
23.04.24 | ABB Hold | Deutsche Bank AG | |
23.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
23.04.24 | UBS Underweight | Barclays Capital | |
22.04.24 | Richemont Buy | Goldman Sachs Group Inc. | |
19.04.24 | ABB Hold | Deutsche Bank AG | |
19.04.24 | ABB Sector Perform | RBC Capital Markets | |
19.04.24 | Zurich Insurance Overweight | Barclays Capital | |
19.04.24 | ABB Neutral | JP Morgan Chase & Co. | |
18.04.24 | Roche Neutral | UBS AG | |
18.04.24 | Novartis Buy | UBS AG | |
18.04.24 | ABB Kaufen | DZ BANK | |
18.04.24 | Novartis Buy | Deutsche Bank AG | |
18.04.24 | ABB Market-Perform | Bernstein Research | |
18.04.24 | ABB Sector Perform | RBC Capital Markets | |
18.04.24 | ABB Neutral | JP Morgan Chase & Co. | |
18.04.24 | ABB Hold | Jefferies & Company Inc. | |
18.04.24 | Givaudan Neutral | UBS AG | |
17.04.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
17.04.24 | Zurich Insurance Overweight | Barclays Capital | |
16.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
16.04.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
15.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
15.04.24 | Zurich Insurance Hold | Deutsche Bank AG | |
15.04.24 | ABB Sector Perform | RBC Capital Markets | |
15.04.24 | ABB Neutral | UBS AG | |
12.04.24 | ams-OSRAM Neutral | UBS AG | |
12.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
12.04.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
12.04.24 | Givaudan Hold | Deutsche Bank AG | |
12.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
11.04.24 | ABB Neutral | JP Morgan Chase & Co. | |
11.04.24 | UBS Overweight | JP Morgan Chase & Co. | |
11.04.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
11.04.24 | Givaudan Sell | UBS AG | |
11.04.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
11.04.24 | Givaudan Reduce | Baader Bank | |
11.04.24 | Givaudan Underperform | Jefferies & Company Inc. | |
10.04.24 | UBS Outperform | RBC Capital Markets | |
10.04.24 | Novartis Buy | UBS AG |